BBOT
#3358
BridgeBio Oncology Therapeutics, Inc. - Common Stock
3.2 6 USD
-0.02%
Market Price
Sektor: Gesundheitswesen
Basis: USD
Gewinnwährung: USD
Tagesspanne
Jahresspanne
Tagesänderung
-1.51%
Monatliche Änderung
-33.60%
6 month change
-63.58%
Jahresänderung
-71.53%
Vorheriger Schlusskurs
3.3 1
Open
3.3 1
Tief
3.2 3
Hoch
3.3 7
Financials
2026
Current report, 08 Sep 2026
Bridgebio Oncology Therapeutics, Inc. current report, 08 September 2026
8-K
Current report, Q3 FY2026
Bridgebio Oncology Therapeutics, Inc. current report, Q3 FY2026
8-K
Quarterly report, Q2 FY2026
Bridgebio Oncology Therapeutics, Inc. quarterly report, Q2 FY2026
10-Q
Current report, Q2 FY2026
Bridgebio Oncology Therapeutics, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
Bridgebio Oncology Therapeutics, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
Bridgebio Oncology Therapeutics, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
Bridgebio Oncology Therapeutics, Inc. current report, Q2 FY2026
8-K
Quarterly report, Q1 FY2026
Bridgebio Oncology Therapeutics, Inc. quarterly report, Q1 FY2026
10-Q
Current report, Q1 FY2026
Bridgebio Oncology Therapeutics, Inc. current report, Q1 FY2026
8-K
Current report, Q1 FY2026
Bridgebio Oncology Therapeutics, Inc. current report, Q1 FY2026
8-K